Vabysmo
Generic: faricimab
Manufacturer: Genentech · Program: Genentech Patient Foundation
Apply for AssistanceEligibility Criteria
Insurance Requirement
Uninsured, underinsured, or insurance coverage is denied by the payer.
Residency
U.S. resident with a valid address in the United States or U.S. Territories.
Income Threshold
Up to 500% FPL
Individual Income Limit
$75,300/year
Calculated based on 500% FPL; Genentech generally provides assistance if household income is under $150,000 for many households.
Program Information
Processing Time
2-3 business days review
Delivery Method
shipped to prescriber
Application Method
Multiple
Reauthorization
Required — annual
Typically Required Documents
ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.
- Completed and signed application form
- Proof of income (e.g., Tax Return, W-2, or recent pay stubs)
- Valid prescription
Indicated For
Neovascular (wet) Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Macular Edema following Retinal Vein Occlusion (RVO)
About This Medication
# How to Get Vabysmo (faricimab) Through the Genentech Patient Foundation --- ## Who Qualifies for the Genentech Patient Foundation? The Genentech Patient Foundation may be able to provide Vabysmo at no cost to patients who meet income and insurance requirements. This is the official patient assistance program run directly by Genentech, the manufacturer of Vabysmo. If you are a single-person household earning up to **$75,300 per year**, you may qualify for free medication. For larger households, the income limit goes higher — up to $156,000 for a family of four. To be eligible, you must be uninsured, underinsured, or have had your insurance coverage for Vabysmo denied by your payer. There is no cost to apply, and most applications are reviewed within 2 to 3 business days. --- ## About Vabysmo (faricimab) Vabysmo (faricimab) is a prescription eye medication made by Genentech. It is FDA-approved to treat three serious eye conditions: neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Vabysmo belongs to a drug class called bispecific VEGF and Ang-2 inhibitors, meaning it targets two different proteins involved in abnormal blood vessel growth in the eye. Because it is a biologic medication administered by injection in a clinical setting, its list price is very high — often thousands of dollars per dose — making it unaffordable for many patients without insurance coverage or financial assistance. --- ## Income Eligibility: Full Breakdown The Genentech Patient Foundation uses income thresholds based on approximately 500% of the Federal Poverty Level (FPL). The limits by household size are: | Household Size | Maximum Annual Income | |---|---| | 1 person | $75,300 | | 2 persons | $102,200 | | 3 persons | $129,100 | | 4 persons | $156,000 | For households larger than four people, income limits continue to increase. As a general guideline, Genentech often provides assistance to households earning under $150,000, though the exact threshold depends on your household size. If your income is above the listed limit for your household size, you may still want to contact the program directly at **(888) 941-3331**, as eligibility can sometimes be reviewed on a case-by-case basis depending on your medical expenses or other financial factors. Income is typically verified using your most recent federal tax return, a W-2 form, or three months of recent pay stubs. You will need to submit at least one of these documents with your application. If your income has changed significantly since your last tax return — for example, due to job loss — pay stubs may give a more accurate current picture and may be worth using instead. --- ## Insurance Requirements Explained Your insurance situation directly affects whether you qualify for this program. Here is how different scenarios are handled: - **If you are uninsured:** You are likely eligible for the Genentech Patient Foundation. Not having any insurance coverage is one of the primary qualifying situations this program is designed for. - **If you have Medicare Part D:** Many manufacturer patient assistance programs exclude Medicare Part D beneficiaries due to federal regulations. Contact the Genentech Patient Foundation at **(888) 941-3331** to ask about your specific situation, as some exceptions or alternative resources may apply. - **If you have private insurance that covers less than 50% of the cost:** You may qualify as "underinsured." The program considers patients underinsured when their plan leaves them with costs they cannot reasonably afford. - **If you have Medicaid:** Medicaid patients are generally not eligible for manufacturer assistance programs, as Medicaid is designed to cover prescription costs for qualifying low-income individuals. If Medicaid does not cover Vabysmo in your state, contact the program to discuss your options. --- ## Step-by-Step: How to Apply Follow these steps to apply for free Vabysmo through the Genentech Patient Foundation: 1. **Gather your documents.** You will need a completed and signed application form, proof of income (most recent tax return, W-2, or three months of pay stubs), and a valid prescription for Vabysmo from your doctor. 2. **Get the application form.** Visit the official program page at [https://www.genentech-access.com/patient/brands/vabysmo.html](https://www.genentech-access.com/patient/brands/vabysmo.html) to download the form or begin an online application. 3. **Choose your submission method.** You can apply online through the website above, call **(888) 941-3331** to apply by phone or get assistance completing your application, or fax your completed paperwork to **(877) 231-5196**. 4. **Have your doctor's office involved.** Your prescribing doctor or their staff will need to sign portions of the application and may assist with submission. Many prescriber offices are familiar with this process. 5. **Submit all documents together.** Incomplete applications can slow down review. Make sure all required items — application, income proof, and prescription — are included before submitting. 6. **Wait for confirmation.** The program typically reviews applications within 2 to 3 business days. You or your doctor's office will be notified of the decision. --- ## What to Expect: Timeline and Delivery After you submit a complete application, the Genentech Patient Foundation typically reviews it within **2 to 3 business days**. Approval notification is usually sent to your prescribing doctor's office. If approved, Vabysmo will be **shipped directly to your prescriber** — not to your home. This is because Vabysmo is administered by injection in a clinical setting, such as a retina specialist's office. You do not need to pick up or handle the medication yourself. Your doctor's office will schedule your injection appointment once the medication arrives. Because eligibility is not permanent, you will need to **reapply annually** to continue receiving assistance. --- ## Alternatives If You Don't Qualify If you do not qualify for the Genentech Patient Foundation, there are still options worth exploring: **Biosimilars:** As of the time this guide was written, there are no FDA-approved biosimilar versions of Vabysmo available. This means lower-cost alternatives in the same drug class are not yet an option. **Savings card for insured patients:** If you have commercial insurance, Genentech offers a separate co-pay savings card program. You may be able to reduce your out-of-pocket costs significantly. Visit [https://www.vabysmo-copay.com/](https://www.vabysmo-copay.com/) to learn more and enroll. **State Pharmaceutical Assistance Programs (SPAPs):** Many states offer their own prescription assistance programs for residents who do not qualify for federal programs. Eligibility and benefits vary by state. Contact your state health department or your local Area Agency on Aging for details. **NeedyMeds.org:** This free, nonprofit database lists hundreds of patient assistance programs by drug name or condition. Visit [www.needymeds.org](https://www.needymeds.org) to search for additional resources that may apply to your situation. --- > *This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Genentech. Program terms may change — verify current requirements at [https://www.genentech-access.com/patient/brands/vabysmo.html](https://www.genentech-access.com/patient/brands/vabysmo.html) before applying.* ---
Program information last verified: February 27, 2026
Ready to apply for Vabysmo assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.